help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2005-0588
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
146/12/5151    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watson, E.
Right arrow Articles by Salton, S. R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watson, E.
Right arrow Articles by Salton, S. R. J.
Endocrinology Vol. 146, No. 12 5151-5163
Copyright © 2005 by The Endocrine Society

VGF Ablation Blocks the Development of Hyperinsulinemia and Hyperglycemia in Several Mouse Models of Obesity

Elizabeth Watson, Seung Hahm, Tooru M. Mizuno, Joan Windsor, Carla Montgomery, Philipp E. Scherer, Charles V. Mobbs and Stephen R. J. Salton

Fishberg Department of Neuroscience (E.W., S.H., T.M.M., J.W., C.M., C.V.M., S.R.J.S.) and Brookdale Department of Geriatrics and Adult Development (T.M.M., C.V.M., S.R.J.S.), Mount Sinai School of Medicine, New York, New York 10029; and Departments of Medicine and Cell Biology (P.E.S.), Albert Einstein College of Medicine, Bronx, New York 10461

Address all correspondence and requests for reprints to: Stephen R. J. Salton, M.D., Ph.D., Fishberg Department of Neuroscience, Box 1065, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, New York 10029. E-mail: stephen.salton{at}mssm.edu.

Targeted deletion of the gene encoding the neuronal and endocrine secreted peptide precursor called VGF (nonacronymic) produces a lean, hypermetabolic, hyperactive mouse. Because VGF mutant mice are resistant to specific forms of diet-, lesion-, and genetically induced obesity, we investigated the role that this polypeptide plays in glucose homeostasis. We report that VGF mutant mice have increased insulin sensitivity by hyperinsulinemic euglycemic clamp analysis, and by insulin and glucose tolerance testing. Blunted counterregulatory responses in VGF-deficient mice were likely influenced by their significantly lower liver glycogen levels. VGF deficiency lowered circulating glucose and insulin levels in several murine models of obesity that are also susceptible to adult onset diabetes mellitus, including Ay/a agouti, ob/ob, and MC4R/MC4R mice. Interestingly, ablation of Vgf in ob/ob mice decreased circulating glucose and insulin levels but did not affect adiposity, whereas MC4R/MC4R mice that are additionally deficient in VGF have improved insulin responsiveness at 7–8 wk of age, when lean MC4R/MC4R mice already have impaired insulin tolerance but are not yet obese. VGF mutant mice also resisted developing obesity and hyperglycemia in response to a high-fat/high-carbohydrate diet, and after gold thioglucose treatment, which is toxic to hypothalamic glucose-sensitive neurons. Lastly, circulating adiponectin, an adipose-synthesized protein the levels of which are correlated with improved insulin sensitivity, increased in VGF mutant compared with wild-type mice. Modulation of VGF levels and/or VGF signaling may consequently represent an alternative means to regulate circulating glucose levels and insulin sensitivity.




This article has been cited by other articles:


Home page
EndocrinologyHome page
P. H. Jethwa, A. Warner, K. N. Nilaweera, J. M. Brameld, J. W. Keyte, W. G. Carter, N. Bolton, M. Bruggraber, P. J. Morgan, P. Barrett, et al.
VGF-Derived Peptide, TLQP-21, Regulates Food Intake and Body Weight in Siberian Hamsters
Endocrinology, August 1, 2007; 148(8): 4044 - 4055.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
C. Cocco, C. Brancia, I. Pirisi, F. D'Amato, B. Noli, R. Possenti, and G.-L. Ferri
VGF Metabolic-related Gene: Distribution of Its Derived Peptides in Mammalian Pancreatic Islets
J. Histochem. Cytochem., June 1, 2007; 55(6): 619 - 628.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Bartolomucci, G. La Corte, R. Possenti, V. Locatelli, A. E. Rigamonti, A. Torsello, E. Bresciani, I. Bulgarelli, R. Rizzi, F. Pavone, et al.
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity
PNAS, September 26, 2006; 103(39): 14584 - 14589.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society